Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 435656, 8 pages
http://dx.doi.org/10.1155/2015/435656
Research Article

Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer

1Department of Clinical Laboratory, Kunshan First People’s Hospital, Jiangsu University, Kunshan 215300, China
2Department of Pathology, Chongqing Cancer Institute, Chongqing 400030, China
3Institute of Cancer Research, Central South University, Changsha 410078, China

Received 6 February 2015; Accepted 17 April 2015

Academic Editor: Olav Lapaire

Copyright © 2015 Jianhong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. Schanen and X. Li, “Transcriptional regulation of mammalian miRNA genes,” Genomics, vol. 97, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, “Identification of novel genes coding for small expressed RNAs,” Science, vol. 294, no. 5543, pp. 853–858, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Sayed and M. Abdellatif, “Micrornas in development and disease,” Physiological Reviews, vol. 91, no. 3, pp. 827–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Krol, I. Loedige, and W. Filipowicz, “The widespread regulation of microRNA biogenesis, function and decay,” Nature Reviews Genetics, vol. 11, no. 9, pp. 597–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Shenouda and S. K. Alahari, “MicroRNA function in cancer: oncogene or a tumor suppressor?” Cancer and Metastasis Reviews, vol. 28, no. 3-4, pp. 369–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Tili, J.-J. Michaille, V. Gandhi, W. Plunkett, D. Sampath, and G. A. Calin, “MiRNAs and their potential for use against cancer and other diseases,” Future Oncology, vol. 3, no. 5, pp. 521–537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. W. C. S. Cho, “OncomiRs: the discovery and progress of microRNAs in cancers,” Molecular Cancer, vol. 6, no. 1, article 60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S. T. Jacob, and T. Patel, “MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer,” Gastroenterology, vol. 133, no. 2, pp. 647–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik, “MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells,” Cancer Research, vol. 68, no. 19, pp. 8164–8172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Gabriely, T. Wurdinger, S. Kesari et al., “MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators,” Molecular and Cellular Biology, vol. 28, no. 17, pp. 5369–5380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Liu, H. Wu, T. Liu et al., “Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma,” Cell Research, vol. 19, no. 7, pp. 828–837, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. X. Lu, A. Munitz, and M. E. Rothenberg, “MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression,” Journal of Immunology, vol. 182, no. 8, pp. 4994–5002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. T. Hashimi, J. A. Fulcher, M. H. Chang, L. Gov, S. Wang, and B. Lee, “MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation,” Blood, vol. 114, no. 2, pp. 404–414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Zheng, H. Xue, T. Wang et al., “miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion,” Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 872–880, 2011. View at Publisher · View at Google Scholar
  15. K. Wu, L. Li, and S. Li, “Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies,” Tumor Biology, vol. 36, no. 3, pp. 1973–1981, 2015. View at Publisher · View at Google Scholar
  16. J. A. Chan, A. M. Krichevsky, and K. S. Kosik, “MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells,” Cancer Research, vol. 65, no. 14, pp. 6029–6033, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Volinia, G. A. Calin, C.-G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Feber, L. Xi, J. D. Luketich et al., “MicroRNA expression profiles of esophageal cancer,” The Journal of Thoracic and Cardiovascular Surgery, vol. 135, no. 2, pp. 255–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Slaby, M. Svoboda, P. Fabian et al., “Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer,” Oncology, vol. 72, no. 5-6, pp. 397–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. J. Nam, H. Yoon, S. W. Kim et al., “MicroRNA expression profiles in serous ovarian carcinoma,” Clinical Cancer Research, vol. 14, no. 9, pp. 2690–2695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. V. Iorio, M. Ferracin, C.-G. Liu et al., “MicroRNA gene expression deregulation in human breast cancer,” Cancer Research, vol. 65, no. 16, pp. 7065–7070, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. W.-O. Lui, N. Pourmand, B. K. Patterson, and A. Fire, “Patterns of known and novel small RNAs in human cervical cancer,” Cancer Research, vol. 67, no. 13, pp. 6031–6043, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Toiyama, M. Takahashi, K. Hur et al., “Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer,” Journal of the National Cancer Institute, vol. 105, no. 12, pp. 849–859, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Schetter, S. Y. Leung, J. J. Sohn et al., “MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma,” The Journal of the American Medical Association, vol. 299, no. 4, pp. 425–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Yang, Y. Guo, Y. Du et al., “Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis,” PLoS ONE, vol. 9, no. 5, Article ID e97460, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Zhang, Z. Li, C. Gao et al., “MiR-21 plays a pivotal role in gastric cancer pathogenesis and progression,” Laboratory Investigation, vol. 88, no. 12, pp. 1358–1366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. B. G. Zhang, J. F. Li, B. Q. Yu, Z. G. Zhu, B. Y. Liu, and M. Yan, “microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN,” Oncology Reports, vol. 27, no. 4, pp. 1019–1026, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. W. M. Association, “Declaration of Helsinki, ethical principles for medical research involving human subjects,” in Proceedings of the 52nd WMA General Assembly, Edinburgh, Scotland, 2000.
  29. K. Iriyama, T. Asakawa, H. Koike, H. Nishiwaki, and H. Suzuki, “Is extensive lymphadenectomy necessary for surgical treatment of intramucosal carcinoma of the stomach?” Archives of Surgery, vol. 124, no. 3, pp. 309–311, 1989. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. P. A. Ebert and C. Röcken, “Molecular screening of gastric cancer by proteome analysis,” European Journal of Gastroenterology and Hepatology, vol. 18, no. 8, pp. 847–853, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. R. Singh and P. Rameshwar, MicroRNA in Development and in the Progression of Cancer, Springer, 2014. View at Publisher · View at Google Scholar
  34. M. Ferracin and L. Lupini, “MicroRNA expression profiling and its clinical impact in breast cancer,” in MicroRNAs: Key Regulators of Oncogenesis, pp. 355–367, Springer, 2014. View at Google Scholar
  35. T. A. Farazi, J. I. Hoell, P. Morozov, and T. Tuschl, “MicroRNAs in human cancer,” in MicroRNA Cancer Regulation, vol. 774 of Advances in Experimental Medicine and Biology, pp. 1–20, Springer, Amsterdam, The Netherlands, 2013. View at Publisher · View at Google Scholar
  36. S. S. C. Chim, T. K. F. Shing, E. C. W. Hung et al., “Detection and characterization of placental microRNAs in maternal plasma,” Clinical Chemistry, vol. 54, no. 3, pp. 482–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Lodes, M. Caraballo, D. Suciu, S. Munro, A. Kumar, and B. Anderson, “Detection of cancer with serum miRNAs on an oligonucleotide microarray,” PLoS ONE, vol. 4, no. 7, Article ID e6229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. G. M. Pasinetti, L. Ho, C. Dooley, B. Abbi, and G. Lange, “Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury in OEF/OIF Veterans,” American Journal of Neurodegenerative Disease, vol. 1, no. 1, pp. 88–98, 2012. View at Google Scholar
  39. D.-J. Kim, S. Linnstaedt, J. Palma et al., “Plasma components affect accuracy of circulating cancer-related microRNA quantitation,” The Journal of Molecular Diagnostics, vol. 14, no. 1, pp. 71–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Wang, Y. Yuan, J.-H. Cho, S. McClarty, D. Baxter, and D. J. Galas, “Comparing the MicroRNA spectrum between serum and plasma,” PLoS ONE, vol. 7, no. 7, Article ID e41561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Davis, S. Propp, S. M. Freier et al., “Potent inhibition of microRNA in vivo without degradation,” Nucleic Acids Research, vol. 37, no. 1, pp. 70–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. S. Mcdonald, D. Milosevic, H. V. Reddi, S. K. Grebe, and A. Algeciras-Schimnich, “Analysis of circulating microRNA: preanalytical and analytical challenges,” Clinical Chemistry, vol. 57, no. 6, pp. 833–840, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Li and K. Ruan, “MicroRNA detection by microarray,” Analytical and Bioanalytical Chemistry, vol. 394, no. 4, pp. 1117–1124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. F. Corsten, R. Dennert, S. Jochems et al., “Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease,” Circulation: Cardiovascular Genetics, vol. 3, no. 6, pp. 499–506, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. F. M. Häusler, A. Keller, P. A. Chandran et al., “Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening,” British Journal of Cancer, vol. 103, no. 5, pp. 693–700, 2010. View at Publisher · View at Google Scholar · View at Scopus